![Paul Herrling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Herrling
Directeur/Membre du Conseil chez
University of Basel
Profil
Paul Linus Herrling is currently a Trustee at The Scripps Research Institute, a Trustee at the University of Basel, a Vice President at the Swiss Federal Institute of Technology, and a Trustee at the Foundation for the National Institutes of Health, Inc. In the past, Dr. Herrling served as the Chairman at Novartis Institute for Tropical Diseases Pte Ltd., Director at Chiron Corp., Director at Novartis Institute for Functional Genomics, Inc., Director at Novartis International Pharmaceutical Ltd., and Head-Corporate Research at Novartis International AG.
He was also the Head-Corporate Research at Novartis AG, an Independent Member-Supervisory Board at Evotec SE, Head-Corporate Research at Sandoz AG, Head-Novartis Institutes at Novartis Institutes for Biomedical Research, Inc., and Head-Global Research at Novartis Pharma AG.
Additionally, he served as a Vice President at ETH-Rat from 2008 to 2018.
Dr. Herrling obtained a doctorate degree from the University of Zurich in 1975 and a graduate degree from the same university in 1971.
Postes actifs de Paul Herrling
| Sociétés | Poste | Début |
|---|---|---|
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 03/09/2010 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 03/09/2010 |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 03/09/2010 |
Foundation for the National Institutes of Health, Inc.
 Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Herrling
| Sociétés | Poste | Fin |
|---|---|---|
ETH-Rat
 ETH-Rat ETH-Rat, also known as the ETH Board, is the strategic leadership and supervisory body of the ETH Domain, appointed by the Swiss Federal Council. The ETH Domain includes two federal institutes of technology (ETH Zurich and EPFL), four federal research institutions (PSI, WSL, Empa, and Eawag), and independent complaint bodies. The private company is based in Zurich, Switzerland. ETH-Rat is responsible for governance functions such as strategic leadership, financial and investment planning, real estate and infrastructure management, professorship planning and appointments, personnel matters, legislation, internal audit, risk management, and representation of interests within the ETH Domain. It oversees a real estate portfolio valued at approximately 4.3 billion CHF, ensuring infrastructure supports education, research, and technology transfer missions. ETH-Rat employs systematic controlling and delegates operational implementation to individual institutions, integrating real estate strategy with financial and investment planning on a rolling 12-year horizon. The organization has defined five priority areas for 2025–2028: human and health; energy, climate, and ecological sustainability; responsible digital transformation; advanced materials and key technologies; and engagement and dialogue with society. ETH-Rat manages delegated public-interest tasks, including oversight of specialized centers and services such as the Swiss National Atlas, Center for Security Studies, Swiss National Supercomputing Centre, Swiss Seismological Service, and National Air Pollution Monitoring Network. The ETH Domain promotes open science through its Open Research Data (ORD) program, investing in infrastructure, training, legal frameworks, and career development to enhance accessibility and sharing of scientific outputs. | Corporate Officer/Principal | 01/01/2018 |
| EVOTEC SE | Directeur/Membre du Conseil | 14/06/2017 |
Novartis International Pharmaceutical Ltd.
 Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | 01/11/2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/12/2011 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Formation de Paul Herrling
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Foundation for the National Institutes of Health, Inc.
Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Commercial Services |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Novartis International Pharmaceutical Ltd.
Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Novartis Institute for Tropical Diseases Pte Ltd.
 Novartis Institute for Tropical Diseases Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapies for tropical infectious diseases | Health Technology |
ETH-Rat
ETH-Rat ETH-Rat, also known as the ETH Board, is the strategic leadership and supervisory body of the ETH Domain, appointed by the Swiss Federal Council. The ETH Domain includes two federal institutes of technology (ETH Zurich and EPFL), four federal research institutions (PSI, WSL, Empa, and Eawag), and independent complaint bodies. The private company is based in Zurich, Switzerland. ETH-Rat is responsible for governance functions such as strategic leadership, financial and investment planning, real estate and infrastructure management, professorship planning and appointments, personnel matters, legislation, internal audit, risk management, and representation of interests within the ETH Domain. It oversees a real estate portfolio valued at approximately 4.3 billion CHF, ensuring infrastructure supports education, research, and technology transfer missions. ETH-Rat employs systematic controlling and delegates operational implementation to individual institutions, integrating real estate strategy with financial and investment planning on a rolling 12-year horizon. The organization has defined five priority areas for 2025–2028: human and health; energy, climate, and ecological sustainability; responsible digital transformation; advanced materials and key technologies; and engagement and dialogue with society. ETH-Rat manages delegated public-interest tasks, including oversight of specialized centers and services such as the Swiss National Atlas, Center for Security Studies, Swiss National Supercomputing Centre, Swiss Seismological Service, and National Air Pollution Monitoring Network. The ETH Domain promotes open science through its Open Research Data (ORD) program, investing in infrastructure, training, legal frameworks, and career development to enhance accessibility and sharing of scientific outputs. |
